Abstract View

Author(s): Musab Khan1, Saad Ahmad Khan2, Pathan Faizan Khan3, Mochi Muzammil4, Mohammad Saqib Usmani5

Email(s): 1musabkhan950@gmail.com

Address:

    J.I.I.U’S Ali-Allana College of Pharmacy Akkalkuwa, Dist- Nandurbar (425415) Maharashtra, India.

Published In:   Volume - 3,      Issue - 1,     Year - 2024

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
The pharmacokinetics and efficacy of different medications are influenced by cytochrome P450 enzymes, which are essential for drug metabolism. This abstract delves into the complex roles that P450 plays in catalyzing phase I reactions, including reduction, hydrolysis, and oxidation. P450 isoform genetic polymorphisms and substrate specificity are factors that influence inter-individual differences in drug response, metabolism, and side effects. Comprehending the complex interactions between pharmaceuticals and P450 is crucial for customized medicine, as it allows for medication schedules that maximize therapeutic effects while reducing adverse effects. This review explores the potential applications of P450 knowledge for improved drug development and patient care, as well as the molecular mechanisms and clinical implications.

Cite this article:
Musab Khan, Saad Ahmad Khan, Pathan Faizan Khan, Mochi Muzammil, Mohammad Saqib UsmaniThe Role of Cytochrom P450 in Drug Metabolism. IJRPAS, 2024; 3(1): 117-122.


1.    Elimilygy Mohamed, Vourvahis Manoli, Guo Cen, and Wang D. Diane (2020); "Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies"; Clin Pharmacokinet; 59 (6); 699-714.

2.    "Retracted: Role of cytochrome P450 in drug interactions," Bibi Zakia (2015); Bibi Nutrition & Metabolism "Inhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?" Callaghan Richard, Luk Frederick, and Bebawy Mary, Drug Metab Dispos., 42(4), 623–631.

3.    "Inhibition and induction of CYP enzymes in humans: an update" Hakkola Jukka, Hukkaren Jane, Turpeinen Mila, & Pelkonen Olavi (2020); Archives of Toxicology ; 94; 3671–3722

4.    "Liver Enzyme Induction and Inhibition: Implication for Anaesthesia" by B.P. Sweeny and J. Bromilow        (2018); Anaesthesia ; 61 ; 159-16l

5.    Pharmacokinetics of haloperidol: an update, Kudo S, Ishizaki T, Dec; 37(6): 435-437, 2015.

6.    "Herbal drugs and drug interactions" by Dulger Gul (2012); Marmara Pharmaceutical Journal ; 16: ; 9-22

7.    "Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice" ; Parmaceutics; 12(19); 846; Deodhar Malavika; Al Rihani B Sweilem; Arwood J Meghan; Darakjian Lucky;Dow pamela; turgeon Jacques and Michaud Veronique (2020).


Related Images:



Recent Images



Evaluation of In-Vitro Anti-Diabetic Activity And   Antioxidant Activity In Ethanolic and Hydroalcoholic Extract of leaves of Gymnema Sylvestre
Molecular Docking Approaches in Antibacterial Drug Discovery: Computational Insights into Natural Compounds
In-vitro Evaluation of Anti-Urolithiatic Activity of Hydroalcoholic Extract of Centella asiatica Leaves
Quality by Design (Qbd) Based Method Development and Validation of Trelagliptin Succinate byu RP-HPLC.
Cubosomes: Structure, Preparation Methods, Characterization, and Pharmaceutical Applications
Programmable Oral Drug Delivery Systems: Materials, Device Engineering, Stimuli-Responsive Mechanisms, and Clinical Translation
Biomimetic Nanocarrier for Targeted Drug Delivery: An Integrated Review
From Phosphate Wasting to Targeted Therapy: An Updated Review of FGF23-Mediated Hypophosphatemic Rickets
Nanotechnology-Based Drug Delivery Systems for Alzheimer’s Disease: Emerging Strategies for Blood–Brain Barrier Targeting
Explainable AI in Pharmacy: Building Trust in AI-Based Drug Recommendation

Tags